Vflow21

Neurovascular Diseases Solutions

Health Tech & Life Sciences
Active
Series A Tel Aviv-Yafo, Israel Founded 2021
Website ↗ LinkedIn
Last updated 2026-06-18
Total raised
—
Last: 2025-04
Stage
Series A
Founded
2021
Headcount
7
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences

About

Vflow21 is a medical device company that develops innovative solutions for neurovascular diseases. The company focuses on Idiopathic Intracranial Hypertension and Tinnitus Treatment.

Funding history · 2 rounds · — total

2025-04
Undisclosed
★ Sanara Capital
2023-06

Q&A

What is Vflow21's primary focus?
Vflow21 is a medical device company that develops innovative solutions for neurovascular diseases, with a specific focus on Idiopathic Intracranial Hypertension and Tinnitus Treatment.
When was Vflow21 founded?
Vflow21 was founded in July 2021.
Who are the co-founders of Vflow21?
The co-founders of Vflow21 are Anat Horev, who serves as Co-Founder, co-CEO & CMO, and Bilha Cahana, who is Co-founder & co-CEO.
What is Vflow21's current funding stage?
Vflow21 is currently in its Series A funding stage.
When did Vflow21 last raise funding and who participated?
Vflow21 last raised funding in April 2025, with Sanara Capital participating in the round.
Which investor participated in Vflow21's June 2023 funding round?
The Israel Innovation Authority participated in Vflow21's funding round in June 2023.
What sector does Vflow21 primarily operate in?
Vflow21's primary sector is Health Tech & Life Sciences.

Team · 2

Anat Horev
Founder · Co-Founder, co-CEO & CMO
LinkedIn ↗
Bilha Cahana
Founder · Co-founder & co-CEO

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Tags

stentvascularneurovascularmedical-devices
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)